Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer.
Itami J, Murakami N, Watanabe M, Sekii S, Kasamatsu T, Kato S, Hirowatari H, Ikushima H, Ando K, Ohno T, Okamoto H, Okuma K, Igaki H. Itami J, et al. Among authors: kasamatsu t. Front Oncol. 2022 Jan 13;11:809825. doi: 10.3389/fonc.2021.809825. eCollection 2021. Front Oncol. 2022. PMID: 35096614 Free PMC article. Review.
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial.
Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito A, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Murakami N, et al. Among authors: kasamatsu t. Jpn J Clin Oncol. 2022 Aug 5;52(8):859-868. doi: 10.1093/jjco/hyac072. Jpn J Clin Oncol. 2022. PMID: 35470390 Clinical Trial.
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors.
Isohashi F, Takano T, Onuki M, Arimoto T, Kawamura N, Hara R, Kawano Y, Ota Y, Inokuchi H, Shinjo H, Saito T, Fujiwara S, Sawasaki T, Ando K, Horie K, Okamoto H, Murakami N, Hasumi Y, Kasamatsu T, Toita T. Isohashi F, et al. Among authors: kasamatsu t. Int J Clin Oncol. 2019 May;24(5):575-582. doi: 10.1007/s10147-018-01380-z. Epub 2018 Dec 22. Int J Clin Oncol. 2019. PMID: 30580379 Free PMC article.
Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Okamoto H, Murakami N, Isohashi F, Kasamatsu T, Hasumi Y, Iijima K, Nishioka S, Nakamura S, Nakamura M, Nishio T, Igaki H, Nakayama Y, Itami J, Ishikura S, Nishimura Y, Toita T. Okamoto H, et al. Among authors: kasamatsu t. Radiat Oncol. 2019 Jul 29;14(1):133. doi: 10.1186/s13014-019-1340-y. Radiat Oncol. 2019. PMID: 31358026 Free PMC article.
Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Murakami N, Isohashi F, Hasumi Y, Kasamatsu T, Okamoto H, Nakamura K, Shibata T, Ito Y, Ishikura S, Nishimura Y, Yaegashi N, Toita T. Murakami N, et al. Among authors: kasamatsu t. Jpn J Clin Oncol. 2019 Sep 1;49(9):881-885. doi: 10.1093/jjco/hyz098. Jpn J Clin Oncol. 2019. PMID: 31613355 Clinical Trial.
Radiation therapy for stage IVA cervical cancer.
Murakami N, Kasamatsu T, Morota M, Sumi M, Inaba K, Ito Y, Itami J. Murakami N, et al. Among authors: kasamatsu t. Anticancer Res. 2013 Nov;33(11):4989-94. Anticancer Res. 2013. PMID: 24222140
400 results